A. Demina, Fazly I. Ataullakhanov, Marie-Christine Alessi, Mikhail A. Panteleev, Hysteresis-like binding of coagulation factors X/Xa to procoagulant activated platelets and phospholipids results from multistep association and membrane-dependent multimerization, BBA -Biomembranes (2016), doi: 10.1016/j.bbamem.2016 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Keywords: blood platelets, blood coagulation, coagulation factor X, phosphatidylserine, annexin V, membrane-dependent reaction
Blood coagulation is a complex reaction cascade in plasma that regulates formation of fibrin network serving to stop bleeding upon vascular injury. It plays vital roles in hemostasis, thrombosis, angiogenesis, cancer and immunity. However, only a minor portion of the coagulation reactions occur in blood plasma itself. All main processes are actually two-dimensional reactions localized to the membranes of either activated platelets, endothelial cells or damaged subendothelium, or microparticles shed by these cells [1, 2] .
Platelet stimulation with potent agonists such as thrombin or collagen leads to externalization of phosphatidylserine by a subpopulation of them allowing efficient binding of coagulation factors to this subpopulation [3, 4] . Among the most important of them are serine protease factor Xa (fXa) and its precursor factor X (fX) that play critical roles in the enzymatic complexes of intrinsic tenase and prothrombinase, respectively [5] . This binding is mostly mediated by "calcium bridges" that connect negatively charged phospholipids with gamma-carboxyglutamic-acid-rich regions in these proteins [6, 7] . In addition to dramatic acceleration of coagulation, this binding might be important for protection of coagulation factors from plasma inhibitors [1, 2] and from rapid flow that can wash them out of a thrombus unless they stick to activated platelets.
As coagulation factor binding to phosphatidylserine-containing membranes is the first step in all membrane-dependent reactions, its understanding is a key prerequisite for the analysis of their mechanisms. Several studies reported rates and binding parameters for the association of fX/fXa with purified phospholipid membranes [8] [9] [10] [11] . Still, the mechanism of this binding paradoxically has never been studied in detail, and data on the binding to natural activated platelet membranes (where surface proteins were reported to additionally contribute to the interactions [12] ) are limited [13, 14] . Only one group provided evidence that binding to phosphatidylserine-containing membrane might lead to a dimerization of one of these factors, fXa [15, 16] . Still, it is unclear whether this dimerization has any physiological importance or an effect on the factor binding/dissociation.
Here we studied interaction of fXa and fX with phospholipid membranes (either vesicles or in a sensor chip-bound form) and activated platelets (both in suspension and within a real thrombus) using flow cytometry, confocal microscopy, surface plasmon resonance and mathematical modeling. Their binding and dissociation in all cases followed a hysteresis-like manner, with plateau concentrations achieved during association much below those observed during factor dissociation (at the one and the same free concentration in solution). Several lines of evidence indicated that this was due to two mechanisms: two-step association (with the second stage tightly bound) and formation of a tightly bound oligomers on the membrane. This suggests a possible role of this mechanism as a way to "lock" bound factor within a thrombus thus protecting it from inhibition in plasma and from flow.
EXPERIMENTAL PROCEDURES
Reagents. The following materials were obtained from the sources shown in brackets: thrombin (Haematologic Technologies, Essex Junction, VT, USA); fXa and fX (Enzyme Research Laboratories, South Bend, IN, USA); Fura Red, 1,1-dihexadecyl-3,3,3,3-tetramethylindocarbocyanine perchlorate (DiIC16(3)), and fluorescein-5-isothiocyanate (FITC) (Molecular Probes, Eugene, OR, USA); prostaglandin E1 (PGE1) (MP Biochemicals, Irvine, CA, USA); HEPES, bovine serum albumin, Sepharose CL-2B, apyrase grade VII, PBS, EDTA (Sigma-Aldrich, St Louis, MO, USA); L-α-phosphatidylserine (Brain, Porcine) and L-α-phosphatidylcholine (Brain, Porcine) (Avanti Polar Lipids, Alabaster, AL, USA)
Blood collection and platelet isolation. Investigations were performed in accordance with the Declaration of Helsinki under a protocol approved by the institutions' Ethical Committee, and written informed consent was obtained from all donors and patients. Blood was collected from healthy adult volunteers into 106 mM sodium citrate (9:1) and supplemented with apyrase (0.1 U/ml) and PGE1 (1 μM). Platelets were purified by gel-filtration as described [3, 17, 18] . Briefly, platelet-rich plasma was obtained by an 8-min centrifugation at 100 g. After further addition of 106 mM sodium citrate (3:1), PRP was centrifuged for 5 min at 400 g, platelets were resuspended in buffer A (150 mM NaCl, 2.7 mM KCl, 1 mM MgCl 2 , 0.4 mM NaH 2 PO 4 , 20 mM HEPES, 5 mM glucose, 0.5% bovine serum albumin, pH 7.4) and gel-filtered on a Sepharose CL-2B column. For experiments involving cytosolic calcium determination, platelets were preincubated for 30 min with Fura Red, 3 U/mL apyrase, and 3 μM PGE1 before gel filtration. Platelets were activated at 5×10 7 /mL for 15 min with 100 nM thrombin in the presence of 2.5 mM CaCl 2 .
Patients. The patient with gray syndrome at the Timone Hospital in Marseille (GPS1) lacked alphagranules as determined by flow cytometry and confirmed by electron microscopy. She possessed NBEAL2 c ins TCCTTCATCAC mutation in exon 46. Her platelets had decreased aggregation with all agonists. Three additional gray syndrome patients (GPS2, GPS3 and GPS4) at the Rogachev Center in Moscow [19] were relatives with an autosomal dominant familial version of the syndrome. They had mild bleeding and decreased aggregation in response to ADP, but not to ristocetin. The diagnosis was based on the presence of gray platelets in stained smear samples and essential decrease in the alpha-granular flow cytometry markers P-selectin, factor V and fibrinogen.
Preparation of phospholipid vesicles. Synthetic phospholipid vesicles of 75% PC / 25% PS were prepared with a protocol recommended by Avanti Polar Lipids (Alabaster, AL, USA) with minor modifications [20] . For binding studies, a lipophilic fluorescent dye DiIC16 (3) in ethanol was added at 0.2 mol%. Phospholipids transferred to a round bottom flask and dried for 30 minutes under a nitrogen stream. Then they were hydrated for 30 min in a buffer of 20 mM HEPES, 140 mM NaCl, pH of 7.5 for T>50 °C. The resulting solution was subjected to a freeze-thaw cycle. Then solution was heated to T>50 °C and particles were formed by extrusion, the membrane pore diameter was of 800 nm. The vesicles were stored at +4 °C and were used within four days of preparation.
FX and fXa labeling. Dialyzed fX (fXa) was supplemented with 0.1 M sodium bicarbonate (pH 9.0), 10 mg/ml FITC (MR=5), and incubated with continuous stirring for 2 h (4°C). The reaction was stopped by 30 min incubation with 1.5 M hydroxylamine (pH 8.5). Then, the reaction mixture was centrifuged for 1 min at 16,000 g in Sephadex G-25 spin columns to separate the conjugate from unreacted labeling reagent. The degree of labeling was controlled by spectrophotometry, and retention of the activity was tested with an APTT-based clotting fX assay (Renam, Russia). The FX activation capacity confirmed that ≥ 80% of the total protein corresponded to a non-activated factor.
Equilibrium binding experiments. For the binding assay, 25:75 PS:PC vesicles (5 μM) or thrombin-(100 nM) activated platelets (5×10 4 cells in μl) were incubated for 20 min with FITC-fX (FITC-fXa) in buffer A with CaCl 2 (2.5 mM). Then suspension was analyzed in a flow cytometer BD Accuri C6 ( BD Bioscience, San Jose, CA, USA). PS-positive platelets were gated by high calcium concentration using dye Fura Red loaded as described [ Fluorescence intensity was converted to the mean number of molecules per platelet using a calibration curve obtained with calibration GFP-conjugated beads. GFP was conjugated to the surface of streptavidin-coated beads with the help of biotinylated oligonucleotides. The number of bead-bound GFP was determined by TIRF microscopy.
Kinetic binding experiments. FX (250 nM) and fXa (30 nM) were incubated with 25:75 PS: PC vesicles (5 μM) or thrombin (100 nM) activated platelets (5×10 4 cells in μl) at room temperature. After addition of fX (fXa), aliquots were taken and analyzed by flow cytometry at time intervals of 0, 0.25, 1, 2, 5, 10, 15, 20, 30 min. When saturation of binding was achieved, the sample was rapidly diluted 20-fold with buffer A containing CaCl 2 , and dissociation was monitored. The association and dissociation curves for individual experiments were fitted with model with a single exponential.
Binding of factors to thrombi formed under arterial shear conditions. Glass cover slips (24×24 mm, Heinz Herenz, Hamburg, Germany) were cleaned with potassium dichromate, rinsed with distilled water and dried. The cleaned cover slips were coated with 200 μg/ml collagen in buffer A for 1 hour at room temperature in a humid atmosphere, and then rinsed with distilled water, and finally assembled as part of the flow chamber. The flow chamber was incubated with BSA to 30 min to shield uncovered patches of glass with BSA before they were exposed to a blood.
Citrated blood of a healthy donor was recalcified and flowed through a parallel plate flow chamber, sealed with a collagen-coated cover slip, at a shear rate of 500 s −1 . Then flow chamber was washed with buffer A with CaCl 2 . First fXa (5 nM) was perfused through a parallel plate flow chamber for 2 min. After that fXa (50 nM) was perfused for 2 min, then fXa (5 nM) for 5 min again. Finally flow chamber was washed with buffer A with CaCl 2 for 5 min. Confocal images were captured in real time using an Axio Observer Z1 microscope (Carl Zeiss, Jena, Germany).
Surface plasmon resonance experiments. Liposomes were prepared by the extruder technique and containing either PS: PC in the ratio 25:75. Liposomes were bound to the L1 sensor chip for 20 min at 25 °C, the flow rate was 1µl/min. Then lipid coated chip was blocked with 0.2 mg/mL BSA for 20 min the flow rate was 1µl/min. Binding experiments were performed using Biacore 3000 instrument (GE Healthcare). For this assay, we used HBS-N buffer (10 mM HEPES pH7.4, 150mM NaCl). The liposomes composed of PS:PC (25:75) were prepared by the extruder technique [Panteleev, FEBS J 2006] , and immobilized onto the L1 sensor chip for 20 min at 25°C at the flow rate of 1 µl/min. The surface was blocked by BSA (0.2 mg/mL) passed for 20 min at the flow rate of 1 µl/min. Association of fX, taken at 50 nM, 100 nM, 200 nM, 400 nM and 800 nM in the HBS-N buffer supplemented with 2.5mM CaCl2, with the lipid was recorded for 5 min at a flow rate of 10ul/min; the control injection of the buffer only was performed. This was followed by recording of fX dissociation for 5 min in the buffer only. The resulting signals were subtracted by the signals recorded from the control flow path not containing the immobilized lipid. Between the injections, sensor chip was regenerated in the HBS-N buffer supplemented with 10 mM EDTA.
Chemical cross-linking and SDS-PAGE. For the cross-linking experiments, the protein was incubated with the phospholipid vesicles (5 µM) or alone in the presence of 2.5 mM CaCl2. Then PFA 0.5% was added for 5 min. After that, cross-linking reaction was stopped by addition of glycine (1.5 M) for 30 min. Then, 100 µl solution was supplemented with 60 µl methanol, 120 µl chloroform and 450 µl water. It was was centrifuged at 13 000 g for 5 min. Water was removed, and 450 µl of methanol was added. The solution was centrifuged at 13 000 g for 5 min. Supernatant was removed, and pellet was resuspended with sample buffer for electrophoresis. The products of cross-linking reaction were analyzed by SDS-PAGE.
Computer model of fXa/fXa binding to phospholipid membranes. Simulations of fX and fXa binding to 25:75 PS:PC vesicles were run using the COPASI software (http://copasi.org). Based on our experiments we have constructed several computational models of the factor binding to a vesicle. All models included fX/fXa binding to a binding site on the membrane and further stabilization (-2-Step‖ model), or dimerization and trimerization of the bound factors (-Trimerization‖ model), described by mass action kinetics. The rate constants of the model were fitted to describe both time course and titration data using a parameter estimation tool (Differential Evolution Method). The equations of the models and parameters of the best fits are given on Fig. 5 .
Computer model of fXa binding to platelets in suspension. Simulations of fXa binding to a single platelet or to a platelet aggregate were run using the Virtual Cell environment (http://vcell.org). Based on our experiments we have constructed a computational model of fXa binding to a platelet in suspension, which included fXa binding to a binding site on the membrane and further dimerization and trimerization of factors, described by mass action kinetics. The rate constants of the model were fitted using a parameter estimation tool in the COPASI software (http://copasi.org). The initial number of binding sites appeared to be donor-specific. The model is accessible at http://vcell.org/vcell_models/published_models.html under the name of Public BioModels/agolomy/fX_platelet_binding.
Computer model of fXa binding to platelets in a thrombus. Then we constructed an in silico aggregate consisting of 15 platelets, each capable of binding of fXa with parameters obtained in the model of fXa binding to platelets in suspension described above. The dimensions of the aggregate were 10´12 µm. The maximal time step was 0.1 s. To ensure simulation accuracy, the results were compared to those obtained with finer mesh size and smaller time steps. Mesh size, maximal time step, and tolerances were adjusted as necessary. The model is accessible at the Virtual Cell website http://vcell.org/vcell_models/published_models.html under the name of Public BioModels/agolomy/fX_thrombus_binding.
RESULTS

Phospholipid-or platelet-bound fX and fXa include both reversibly and irreversibly bound fractions.
As a first step, fX and fXa were labeled with fluorescent dyes, incubated with activated platelets or PS:PC (25:75) vesicles and analyzed using flow cytometry (Fig. 1A, B ). Strongly activated platelets are known to segregate into two subpopulations, which differ by the presence of phosphatidylserine in the outer layer of the membrane (PS-positive and PS-negative subpopulations) [21] . In agreement with previous reports [3] , two subpopulations of activated platelets were observed, with high factor binding to the subpopulation having high cytosolic calcium and almost negligible (and calcium-independent) binding to the one having low calcium (Fig. 1A,B) .
Association of the factors with phosphatidylserine-expressing activated platelets was rapid and proceeded until a plateau resembling equilibrium (Fig. 1C, D) . However, the fX and fXa dissociation was unexpectedly a two-step process resulting in a plateau that was up to 10-fold greater than the plateau observed in the association experiments with the same free factor concentration (see insets for each panel). In other words, the overall binding and dissociation process was hysteresis-like, demonstrating a kind of "memory". Or, to put it differently, the bound factor was comprised of two fractions, reversibly-and irreversibly-bound ones.
Exactly the same hysteresis-like behavior was observed for binding of fX and fXa to the phospholipid vesicles (Fig. 1E, F) , although the binding kinetics differed essentially, and although there was an additional high-affinity binding site for fXa on platelets (Table 1 ). This indicated that this phenomenon was not due to some specific platelet receptors.
FXa binding to platelets lacking factor Va. The main qualitative difference between platelets and phospholipids was appearance of an additional apparent high-affinity binding site for fXa on activated platelets (Table 1) , which agrees well with the accepted concept that such additional high-affinity binding sites are provided by α-granule-released factor Va on stimulated platelets [23] and with the values reported before [J Biol Chem 1985; 260: 2119-24] . This was confirmed in the experiments using platelets from a gray syndrome patient GPS1 (Fig. 2) : the hysteresis phenomenon remained, and only high-affinity sites disappeared. Similar results were obtained with two other patients GPS2 and GPS3. These data additionally confirmed that the unusual hysteresis-like behavior does not require any platelet-specific proteins and can be explained purely by interactions of these two factors with phospholipids.
Characterization of the fX and fXa binding. In agreement with previous reports [3, 5, 9, 22] , the coagulation factor binding was calcium-dependent and specific as determined in the experiments in the presence of excess of unlabeled factor (Fig. 3A) or EDTA (Fig. 3B) , with apparent parameters given in Table 1 . Binding to the PS-negative subpopulation was negligible and did not exceed nonspecific binding (Fig. 3B) in agreement with previous reports [3] .
When experiments similar to those in Fig. 1 were carried out in a wide range of protein concentrations using 2-fold concentration increases or dilutions, hysteresis phenomenon remained (Fig. 3C, D) . The idea of this experiment was to measure bound fX level twice: either by its direct addition, or by an addition at a higher concentration followed by a two-fold dilution. The results show that, for the whole range of factor concentration, the bound factor level is higher is it is obtained by a dilution rather than by a direct addition.
To investigate possible differences in case of dual-agonist platelet activation, we performed additional experiments on fXa binding and dissociation for platelets stimulated with thrombin and collagen-related peptide (Fig. 3E) . All effects were exactly the same as for thrombin-produced procoagulant platelets. The residual binding could be completely removed by EDTA confirming that is is not due to fluorophore insertion to the membrane or another Gla-independent activity. Experiments (Fig. 3F) .
Characterization of the hysteresis observation. To test whether hysteresis would be observed with other, better-established methods of studying protein-membrane interactions, we carried out experiments using SPR lipid binding assay (which is a classical approach, highly sensitive with good temporal resolution and not requiring protein labeling). In agreement with the flow cytometry data, there was a clearly observed hysteresis effect (Fig. 4A) ; there was an irreversibly bound fraction of fX in each experiment.
The majority of the experiments in the present study were carried out with 2.5 mM CaCl 2 and phospholipid composition of 25:75 PS:PC, which is a classical model for such studies. However, we studied whether hysteresis would remain under more physiological conditions (Fig. 4B-D) . The phenomena observed with 12:88 PS/PC (Fig. 4B) , or with 1.5 mM calcium (Fig. 4C) were indeed perfectly similar to the ones observed with 25:75 PS:PS and 2.5. mM calcium (Fig. 4D) .
When association of fX and fXa at different concentrations was compared (Fig. 4E,F) , the degree of fX retention did not depend on fX concentration (Fig. 4E) , while fXa was retained much better at 250 nM than at 25 nM (Fig. 4F) .
Finally, we carried out experiments with dilutions at different timepoints after association. These led to different plateau concentrations of bound fXa despite the same concentration in solution (Fig.  4E) . These data suggest that the hysteresis phenomenon is due to some process on the membrane that, with time, transforms fX and fXa into more tightly bound forms. Two possibilities could be multistep association (when each single bound molecule becomes increasingly attached with time) or multimer formation (when molecules bind each other to become more attached). FXa is particularly suspected of dimer formation on the lipid surface [14] . Such a case could explain, in particular, while there was such a poor displacement of the membrane-bound factor in Fig. 3A despite adding unlabeled factor at the concentration greatly exceeding those of the labeled factor and the apparent Kd: that is because only monomers are readily displaced.
Multistep association and multimerization can explain the hysteresis in the membrane binding of fX/fXa.
To investigate these possibilities, we developed kinetic computational models of fX/fXa binding to phospholipid vesicles. Two main versions of the model were "2-Step" binding ( Fig. 5A ) assuming formation of a tightly bound monomer form with time and "trimerization" (Fig. 5B) assuming formation of tightly bound multimers.
It turned out that the experimental "hysteresis" phenomenon itself could be equally well described by any of the models for both fX and fXa (Fig. 5C-D) , with some minor differences. Model parameters obtained by fitting experimental data are indicated in the figures.
In order to differentiate between possible mechanisms, we performed simulations and experiments on fX binding to lipids in the presence of unlabeled fX (Fig. 5E) , and did the same for fXa (Fig. 5F ). The "2-step" model predicted no improvement of factor binding by addition of its unlabeled counterpart, just some minor competition (compare solid and dotted gray curves). In contrast, "trimerization" model predicted improvement of binding and of retention (compare solid and dotted black curves). Comparison with experiments revealed that fX in all respects seems to follow 2-step model: its binding is slightly inhibited by unlabeled factors, and that is all. For fXa, the pattern is completely different and better agrees with a "trimerization" model. Its binding is prominently promoted by the unlabeled fXa, and retention is also greatly increased. Although there could be various combinations of these mechanisms, it seems that formation of a stabilized membrane-bound form is the main mechanism for the retention fX, while oligomerization is the main mechanism for retention of fXa.
To gain further insight into the mechanisms of the hysteresis, we developed a mathematical model of fXa binding to the platelet membrane taking into account multimerization (Fig. 5B) . The main assumptions of the model was that fXa monomers can associate on the phospholipid surface according to the law of mass action, and that multimers of fXa do not dissociate from the surface at all. In contrast to the factor Xa dimerization model of [Koklic 2009, ref 15 ], we did not assume equilibrium at any of the stages (because it would not allow hysteresis). We had to include formation of at least trimers (in an interesting parallel with what is established for annexin V). All parameters of the model were estimated from our experiments. The initial number of binding sites was donor-specific and was adjusted for each experiment. The model was able to describe experimental data with the hysteresis phenomenon well (Fig. 5G,H) .
Formation of fX-fXa multimers and annexin V retention. An experiment on labeled fXa binding in the presence of unlabeled fX (Fig. 6A ) demonstrated that fX greatly promotes fXa binding. This suggests that multimers can be formed by fX and fXa and this can lead to retention of fXa on the membrane. This can lead to much greater effects that fXa-fXa interactions because the concentration of fX during coagulation exceeds that of fXa by orders of magnitude [27] [28] [29] .
In order to test the possible role of multimers in factor retention, we used a well-characterized phosphatidylserine-binding molecule, annexin V, that is established to form trimers upon membrane binding [24, 25] . Our experiments demonstrated that annexin V exhibits exactly the same hysteresislike behavior like fX and fXa (Fig. 6B) . This is in agreement with the report of Brisson et al. who discovered that membrane-bound annexin V included both reversibly and irreversibly bound fractions [26] . This indirectly confirms that the oligomers of membrane-binding proteins can be more tightly bound to the membrane than the monomers. SDS-PAGE of cross-linked annexin V with and without phospholipid confirmed that phospholipid indeed induce formation of dimers and trimers (Fig. 6C) , in contrast to fX (Fig. 6D) Hysteresis-like binding of factors to platelets in thrombi can protect coagulation factors from flow. It is natural to hypothesize that the hysteresis phenomenon might be important for preventing wash-out of coagulation factors from platelet thrombi by flow, because such wash-out would not only impair thrombus stabilization by fibrin, but also might induce undesired coagulation and embolism downstream. In order to test physiological significance of the hysteresis phenomenon, we first performed computational modeling of fXa interaction with the membrane of activated platelets under flow conditions using the trimer formation model (Fig. 7A ). Simulations were performed for two cases, with and without trimerization (Fig. 6B) . Without multimerization, fXa was eluted from the aggregate within two minutes (solid gray curve). In contrast, fXa able to multimerize remains in the aggregates tightly attached (dash curve), while all monomers are washed by the flow (dot curve).
Finally, we investigated this hypothesis experimentally ( Fig. 7C-E) . Whole blood platelet thrombi were allowed to form in a parallel-plate flow chambers coated with collagen at a shear rate of 500 s −1 . They were then washed, perfused with fluorescently labeled fXa (at two different concentration, 5 or 10 nM), then fXa concentration was increased 10-fold, then decreased 10-fold, and finally the thrombi were washed with buffer A containing CaCl 2 followed by perfusion with EDTA-containing buffer. The results revealed that hysteresis phenomenon persisted in realistic thrombi with naturally occurring fXa concentrations suggesting its physiological importance.
DISCUSSION
The main finding of the present study is that binding of fX and fXa to phospholipid membranes is a more complicated process than believed before: fX and fXa are characterized by multistep association and can form various multimers (including heterogeneous ones composed of both fX and fXa) on the surface of activated platelets. These multimers have the order of at least three, and are more tightly
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8 bound than monomers resulting in a hysteresis-like kinetics of binding and dissociation. In real thrombi, this might protect active coagulation factors by preventing their wash-out by flow. The phenomenon is independend on the platelet activation type and occurs on the phospholipids as well; it is observed within a wide range of protein and calcium concentrations.
To the best of our knowledge, previous studies of the coagulation factor binding to phospholipids almost universally assumed a typical one-site reversible binding model [3, [7] [8] [9] 13] . The only exceptions were a study of Gilbert et al. suggesting a two-step dissociation of coagulation factor VIII from lipids that strikingly resembles data of the present study [30] (quite strikingly, a very recent paper reports that membrane-bound factor VIII is a dimer [http://www.ncbi.nlm.nih.gov/pubmed/26082135]) and the report of the Brisson lab on two fractions of membrane-bound annexin V [26] , the latter one not actually being a coagulation factor.
Here we demonstrate, using several approaches, that binding of both fX and fXa to either purified phospholipid membranes (either those of vesicles or in a SPR chip) or activated platelets (either washed or in thrombi) exhibits the same feature. Membrane-bound factor is composed of two fractions, and only one of them readily dissociates, whicle another is retained.
There are several lines of evidence that this phenomenon is in all likelihood related to multistep association and multimerization of coagulation factor monomers on the phospholipid surface. First, this process does not require platelets and occurs on phospholipid; therefore, it does not require any proteins except for the coagulation factor itself. Second, the hysteresis is much greater for fXa if there is more coagulation factor: this means that interaction of coagulation factor molecules is important (otherwise it would not so strongly depend on their concentration, as is the case for fXa). Third, annexin V known to form trimers has the same behavior. Fourth, we directly show that fX and fXa promote membrane binding of fXa (while fX does not greatly affect fX binding except for minor competition) thus directly demonstrating formation of at least dimers; and for fXa, formation of at least dimers on the membrane was reported before [15, 16] . Fifth, this is supported by the computer simulations that could describe the experiments and give correct predictions. All these lines (including additional crosslinking of proteins) also suggest that the mechanisms for fX and fXa are different, with multimers playing less prominent role for fX.
Additional research using more direct methods (e.g. atomic force microscopy, cryoelectron microscopy of nanoparticle tracking, crosslinking of proteins) is required to observe all types of the multimers multimers, determine their order, and distinguish different steps in multistep association. Computer simulations suggest that the order of oligomerization for fXa should be at least three, but it can be easily much more complicated than that (for example, annexin V trimers do interact with each other [24] [25] [26] ).
The data of the present study do not provide information about the activity of the membrane-bound multimers or different forms of coagulation factor. For fXa, it was previously reported that its dimers are inactive and have to dissociate in order to form functional prothrombinase [15] . This also requires a separate investigation.
We did not study other coagulation factors than fX and fXa, but similarity of the phenomenon to annexin V trimerization and existence of similar dissociation dynamics for fVIII suggest that hysteresis-like binding may be a universal mechanism of the procoagulant factors attachment. It might be also possible that multimerization of both annexin V and factors X/Xa has an impact on the possible modes of their competition on the phospholipid suface.
The flow chamber experiments indicate that this attachment mechanism, in particular, can prevent coagulation factor dissociation in platelet-rich arterial thrombi and, therefore, its inhibition by plasma proteins and removal by flow. It is reasonable to assume that the predominant mechanism should be the fXa-fX interaction, because fX is present at much greater concentrations than fXa during coagulation. However, taking into account the prediction of at least third order multimerization, various combinations of these factors are possible, and specific contributions of different multimers remain to be determined. and microscopy, and Dr. Mikhail Ovanesov (Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, United States) for kindly preparing liposomes for SPR.
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